Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: valueset-fluocortolone-exclude - JSON Representation

Raw json | Download

{
  "resourceType" : "ValueSet",
  "id" : "valueset-fluocortolone-exclude",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>103461</td><td>Fluocortolone Caproate 2.5 MG/ML / Fluocortolone Pivalate                     2.5 MG/ML Topical Cream</td></tr><tr><td>103462</td><td>Fluocortolone Caproate 0.0025 MG/MG / Fluocortolone Pivalate                     0.0025 MG/MG Topical Ointment</td></tr><tr><td>392955</td><td>Fluocortolone Topical Cream</td></tr><tr><td>392957</td><td>Fluocortolone Topical Ointment</td></tr><tr><td>1160822</td><td>Fluocortolone Topical Product</td></tr></table></li></ul></div>"
  },
  "url" : "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-fluocortolone-exclude",
  "version" : "1.0.0-ballot",
  "name" : "Valueset_fluocortolone_exclude",
  "title" : "Exclude Fluocortolone Medications Value Set",
  "status" : "draft",
  "experimental" : true,
  "date" : "2018-07-02",
  "publisher" : "HL7 Clinical Decision Support Workgroup",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description" : "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code" : "001"
        }
      ]
    }
  ],
  "purpose" : "To refine valueset for Warfarin + NSAID PDDI-CDS",
  "copyright" : "(copyright expectations unknown)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "103461",
            "display" : "Fluocortolone Caproate 2.5 MG/ML / Fluocortolone Pivalate                     2.5 MG/ML Topical Cream"
          },
          {
            "code" : "103462",
            "display" : "Fluocortolone Caproate 0.0025 MG/MG / Fluocortolone Pivalate                     0.0025 MG/MG Topical Ointment"
          },
          {
            "code" : "392955",
            "display" : "Fluocortolone Topical Cream"
          },
          {
            "code" : "392957",
            "display" : "Fluocortolone Topical Ointment"
          },
          {
            "code" : "1160822",
            "display" : "Fluocortolone Topical Product"
          }
        ]
      }
    ]
  }
}